© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Tolphenidone first caught attention during the rapid expansion of pharmaceutical synthesis in the mid-20th century. Chemists, scouring for compounds with novel bioactivity, uncovered tolphenidone’s unique core structure. Demand for new anti-inflammatory drugs pushed research teams in German and Japanese labs to screen arylalkylketones and related derivatives. Tolphenidone emerged as an interesting candidate from these efforts, not as a blockbuster, but as a molecule with an elusive profile. Archivists can trace its earliest documentation to experimental series from the 1960s, right as medicinal chemistry started to tackle tough-to-treat pain and inflammation. Although tolphenidone never landed bestseller status, the records show that it provided a bread-and-butter case for how incremental research keeps the field genuine.
Tolphenidone has seen use primarily as a nonsteroidal anti-inflammatory agent. In practice, the product shows up in powder or tablet form, typically as part of specialty pharmacy stocks or research supplies. I once saw a jar of this off-white solid in a university teaching lab, scrawled with a fading label but kept for chemical reference. Modern digital catalogs list tolphenidone among lesser-known NSAIDs, with distributors noting intermittent demand from academic and pharmaceutical chemists. In therapeutic contexts, tolphenidone offered pain relief and inflammation reduction, but rarely became a first-line drug. Clinicians recognized its place as a supporting character: useful for specific applications or investigative protocols.
Tolphenidone presents as an off-white to pale yellow crystalline powder, stable under ambient conditions when kept dry and out of direct sunlight. Its melting range routinely falls between 92°C and 98°C, reflecting a relatively pure solid. Chemically, tolphenidone sits in the arylalkanone class, sporting a thienyl ring attached to a propanone skeleton. Solubility stays moderate in polar solvents – ethanol and acetone dissolve it readily, as I learned during a hands-on extraction in graduate school, but water barely touches it. The compound’s molecular weight clocks in around 199 g/mol, giving it reasonable handling characteristics in both bulk and small-scale research setups. A slightly earthy odor hints at its thienyl group, a feature that also steers downstream modifications.
Labeling of tolphenidone, in accordance with chemical safety standards, emphasizes its batch number, date of manufacture, assay purity (commonly listed at 98% or higher), and hazard information including risk and safety phrases tied to its irritant properties. Specification sheets, such as those I’ve read in both European and North American labs, lay out key identification parameters: melting point range, detailed IR and NMR spectra, and heavy metals content. These fundamental checks ensure reliable performance and minimize contamination risk, which matters both for bench chemists and end-users in clinical manufacturing. Suppliers sometimes add additional information including shelf-life recommendations and waste disposal guidance.
Synthetic chemists approached tolphenidone by building its thienyl-propanone core. The favored pathway starts with thiophene-2-carboxaldehyde, which condenses with acetone (or a suitable equivalent) under basic catalysis, such as sodium hydroxide in an alcohol solvent. The resulting α,β-unsaturated ketone forms through standard aldol condensation, followed by hydrogenation to complete the propanone linkage. Purification involves liquid-liquid extraction and crystallization. Having run similar reactions, I can attest to the importance of finely tuning temperature and reactant ratio to minimize side-products. Today, process chemists look for ways to reduce solvent use and improve yield – green chemistry principles influence this work as regulatory frameworks tighten.
Tolphenidone’s structure makes it amendable to further chemical tailoring. The ketone group reacts with nucleophiles in reduction and reductive amination, creating analogues useful for structure-activity studies. Its thienyl moiety withstands most mild reaction conditions, making substitution more practical at the propanone segment. Labs exploring new derivatives often introduce halogens or alkyl groups to probe anti-inflammatory response, seeking to optimize potency and decrease undesired effects. I’ve seen medicinal chemists use tolphenidone analogues to chart out SAR landscapes, searching for hidden therapeutic value. These reactions help map how tiny tweaks sculpt activity, safety, and pharmacokinetic profile.
The chemical literature and global drug directories recognize tolphenidone under several names. Besides its main designation, it carries the moniker “4-(2-Thienyl)-2-butanone” and CAS number 24438-84-6. Historical documents sometimes use the trade name “Bucethan,” reflecting trademark registrations from the 1970s. Some suppliers label it as “Thienylpropanone.” Every name points to the same molecular blueprint, though packaging, labeling, and documentation differ by jurisdiction and supply chain. In navigating regulatory filings or research papers, following both IUPAC and trade names ensures clear identification and avoids duplicate procurement.
Standard safety protocols apply to tolphenidone handling. MSDS documents list it as an irritant, with precautions necessary to prevent inhalation and skin contact. Fume hood work, nitrile gloves, and splash-proof eyewear suffice under typical scales, but larger operations rely on powder containment systems and local extraction. Disposal guidelines direct users to organic waste streams; local regulations may classify tolphenidone solutions as hazardous due to their biological activity. My own rule in the lab always included pre-mixing any waste with excess base to neutralize before final disposal. Training in spill response and chemical hygiene helps teams stay incident-free. Regular audits, especially for outdated material, prevent accidental exposure and waste build-up.
Although not widely prescribed today, tolphenidone’s primary impact came in the field of anti-inflammatory therapy. Medical practitioners used it to manage pain and swelling stemming from musculoskeletal disorders and some soft tissue injuries, often where better-tolerated NSAIDs failed or proved suboptimal. Veterinary medicine occasionally employed tolphenidone for inflammation control in companion animals. In the research setting, tolphenidone provided a model compound for studying the interaction of thienyl ketones with biological targets, such as cyclooxygenase enzymes. Formulation science utilized it to test delivery systems, especially sustained-release vehicles, since its moderate solubility demanded innovative approaches to absorption.
Ongoing research in the late 20th and early 21st centuries placed tolphenidone in secondary screens for anti-inflammatory drug discovery. At one point, I followed a pharmacology group in Switzerland that used tolphenidone to benchmark new derivatives with improved gastrointestinal tolerability. Structure studies unraveled how its metabolic byproducts shaped both its effect and safety profile. Fresh questions have shifted toward designing novel thienyl-based scaffolds with enhanced selectivity, using tolphenidone’s structure as a starting point. Some biochemists evaluate its binding kinetics with COX isozymes, trying to illuminate what structural tweaks lead to fewer side effects. As drug discovery demands safer painkillers, these research efforts continue, albeit with a longer timeline than headline-grabbing pharmaceutical breakthroughs.
Toxicologists probed tolphenidone’s safety margins both in vitro and in vivo animal models, noting that its toxicity resembled that of older NSAIDs. Noteworthy findings included dose-dependent gastric irritation and mild hepatic stress, features tied to its chemical class. I recall reading studies where chronic exposure in rodents prompted organ weight shifts and gastrointestinal lesions, underscoring a need for careful dosing. Human data remained sparse, reflecting limited clinical deployment, but case reports suggest attention to potential kidney and liver interactions, especially in patients with pre-existing compromise. Regulatory agencies pegged tolphenidone with standard package warnings known for classic NSAIDs, such as risk of GI upset and rare hypersensitivity reactions.
Tolphenidone’s comeback as a frontline drug remains unlikely, but its role as a research compound and potential scaffold for safer NSAIDs has not dimmed. Advances in molecular modeling invite chemists to revisit its core, applying lessons from decades of anti-inflammatory drug failures and triumphs. There’s traction in developing analogues with modified side chains, aiming for targeted enzyme inhibition and fewer side effects. With regulatory climates tightening around established NSAIDs due to cardiovascular and gastrointestinal risks, research into alternatives finds slow but steady funding. Academic consortia and academic-industrial partnerships sift through tolphenidone-like molecules, seeking the elusive ideal—potent anti-inflammatory effect, high safety margin, and affordable synthesis. My experience tells me not to expect miracles from such efforts, but to respect the value of sustained, thorough science. Tolphenidone may linger on the fringes of pharmacotherapy, yet its story echoes a persistent theme in medicinal chemistry: the search never quite ends.
Tolphenidone often turns up in conversations about muscle pain or discomfort. It has carved out its place as a muscle relaxant. Doctors prescribe it to people who spend their days battling muscle spasms, sometimes from an injury or long-term conditions like back pain. It differs from stronger painkillers—it doesn’t cloud the mind or bring the risk of addiction. For that alone, Tolphenidone stands out in a world used to quick but risky fixes.
Muscle pain isn’t glamorous, but it drags down the quality of life. As someone who’s thrown out their back more than once, the smallest movement can trigger sharp pain. Many people reach for the usual painkillers, but often end up with heavy side effects or a foggy head. Tolphenidone works on the muscles themselves, letting them loosen and relax.
There’s plenty of value in a medication that helps people keep up with daily demands without knocking them out for hours. In the hands of professionals, Tolphenidone supports recovery plans that pair medication with therapy or exercise. That’s one reason health systems in several countries include it in their toolkit. Still, it’s hard to ignore the fact that every drug carries some risk.
Every pill promises some relief, but many come with a catch. Tolphenidone is no different. Some people deal with mild troubles—upset stomach, tiredness, a dry mouth. Then there are the rare but serious headaches or allergic reactions, which push careful monitoring to the front. Doctors weigh the benefits and keep an eye on side effects. None of this replaces regular follow-ups or an open channel between doctor and patient.
Misinformation around muscle relaxants floats around, mostly because many don’t realize there isn’t one cure for all muscle problems. If Tolphenidone finds its way into someone’s cabinet, a frank conversation with the doctor helps set the right expectations. It’s not a magic fix. Most people will get better results when the medicine supplements physical therapy, stretching, or adjustments to the daily routine.
Plenty of folks who receive Tolphenidone also want advice on living better with pain. They look for tools that help them work, play, and sleep without constant aches. Some health professionals run workshops or offer printed guides for these situations. Simple changes—standing up every hour, gentle stretching, heat packs—sometimes make all the difference.
Reliance on any pill can lead to trouble, but knowledge isn’t just an antidote—it’s a shield. Doctors can take time to review the patient’s whole story, looking at lifestyle, posture, or even stress. Too many people get caught in a loop of medication because nobody paused to suggest better shoes or an ergonomic chair.
People who find relief with Tolphenidone often want their lives back, not just a break from pain. Family members feel the stress, workplaces suffer from lost productivity, and communities want people thriving, not sidelined. That’s why a holistic approach wins out. Pain management teams that mix Tolphenidone, physiotherapy, and sensible advice see better results than medication alone.
The future for Tolphenidone depends on how it’s used—with respect, understanding, and a focus on more than just symptoms. Science keeps looking for better treatments, but right now, good practice puts Tolphenidone in a supporting role. People deserve relief that lets them keep their edge during the day and rest easy at night.
Tolphenidone entered the market as a muscle relaxant, and there’s no shortage of people counting on it to manage pain from muscle spasms or injuries. But every treatment choice comes with tradeoffs. Doctors and patients both run into a catch-22: ease the symptoms, or risk new problems brought on by the medicine itself. Trying to make sense of the potential side effects means moving beyond the label and into what actually shows up in clinics and daily life.
Dry mouth tops the list for many folks who take tolphenidone. The mouth feels parched, food tastes off, and talking for long periods can make gums hurt. Some get headaches that tend to drag through the day. Nausea isn’t rare. You’ll sometimes see people mention feeling tired, the sort of drowsiness that makes it tough to focus at work or while driving. Dizziness can surprise you, especially when standing up quickly. Constipation has caught some off guard, disrupting more than one busy morning. These side effects overlap with other muscle relaxants, but the frustration often piles up until people can’t ignore it.
Rare doesn’t mean never. Allergic reactions hit a small group—rash, swelling, or the scary sense that your throat is closing. A few have seen drops in blood pressure, leading to weak legs or even fainting. Others talk about rapid heartbeats or pounding in the ears. While the risk stays low, anyone whose job demands alertness—road workers, machine operators, health care staff—faces bigger risks with these symptoms. European health regulators once flagged liver problems with tolphenidone, noticing that liver enzymes could rise, signaling trouble. Even mild jaundice is something you don’t want to miss and should be watched for with regular checkups. Liver injury from medicines catches folks off guard because early symptoms slip by so quietly at the start.
Hiding side effects or toughing them out can get dangerous fast. I’ve seen plenty of people shrug off warning signs, hoping they’ll fade. In reality, doctors need the whole picture to weigh benefit against harm. Honest conversations about sleepiness, blood pressure swings, or unusual weakness help doctors fine-tune doses. Sometimes, using different muscle relaxants makes sense. If mild problems drag on, a simple switch can improve quality of life without sacrificing pain relief. Everyone deserves a say in their own care plan, but it runs smoother with clear feedback between the clinic and real life outside it.
Simple steps make a difference day-to-day. Sipping water eases the impact of dry mouth. Light snacks help with queasiness brought on after a dose. Sticking with regular walks or light exercise relieves constipation. Careful standing puts the brakes on dizziness or lightheadedness. If medications stack up, double-check with a pharmacist, because tolphenidone can clash with alcohol, antihistamines, or sleeping aids, all of which ramp up the risk of extreme drowsiness. Family support proves valuable. Small reminders to check in about new symptoms or changes in routine can catch issues before they grow into emergencies.
Pain management has never been simple. Tolphenidone serves a role for people who can’t get by on over-the-counter painkillers alone. Understanding the common, rare, and overlooked side effects lets people make choices that fit their daily demands and long-term health. Better conversations and patient education make side effects less of a guessing game and more of a manageable reality for those who need muscle relief in everyday life.
Tolphenidone serves as a non-steroidal anti-inflammatory drug (NSAID) used to help manage pain and inflammation, but it doesn’t get as much attention as others in its category. In my years working with patients and reviewing their medication routines, the same questions come up again and again: how to take it safely, what side effects to watch for, and what’s the best way to fit it into daily life without risking health.
Patients often feel unsure about dosing schedules and what foods or habits could make a difference. Based on decades of research and my direct involvement with medical teams, I always stress the same rule: take tolphenidone with food or a full glass of water. This reduces stomach irritation, which is a major concern with NSAIDs. Skipping breakfast and popping the pill can put your gut at risk. I have seen more than a few folks wind up with gastritis or ulcers simply from taking their medication on an empty stomach. If you tend to forget your pills, tie this dose to a daily routine, such as a meal you never miss.
Dosing schedules aren’t just suggestions; doctors base them on how the drug works in the body. Sticking to the prescribed timing holds more value than people realize. It’s tempting to double up after a missed dose or think a little extra will help the pain go away faster. That line of thinking can create more trouble than it solves. A conversation I had with a community pharmacist comes to mind–he’d seen cases where patients ramped up NSAID dosing after injury and ended up with kidney issues or stomach bleeding. The bottom line: follow the prescribed schedule, and don’t play guessing games with the dose.
From a clinician’s point of view, ongoing monitoring is just as important as the initial prescription. Blood pressure can sneak up, digestive trouble can appear out of the blue, and rare but serious reactions such as allergic rashes could surface. My advice: write down any unusual symptoms–don’t rely on memory at the doctor’s office. If a rash, swelling, trouble breathing, or black, tarry stools show up, seek medical help right away. Patients with a history of ulcers, asthma, heart, or kidney problems need extra attention. I encourage discussions with your doctor before starting tolphenidone, and again every few months if you rely on it long-term.
Some believe over-the-counter pain relievers are always safer, but those with chronic pain sometimes lean heavily on tolphenidone, believing prescription equals “stronger and better.” That’s not always the case. In people over sixty or those with health problems, NSAIDs pose real risks. Acetaminophen or non-drug approaches, such as heat therapy or physical therapy, might align better with long-term safety–another lesson learned from working in hospital wards full of patients who ignored early warning signs.
Finally, don’t mix and match pain relievers or share prescriptions. Every year, the poison control lines light up with calls about such missteps. Good communication with doctors beats self-experimentation every time. In my experience, patients who check in regularly about their pain control do better, avoid complications, and limit long-term harm.
Tolphenidone has its place for certain patients, but health outcomes always improve with thoughtful conversations, careful monitoring, and respect for the instructions on the bottle. People who pay attention to how, when, and why they take this medication–instead of leaving things to chance–protect themselves against unexpected problems and build a better foundation for managing pain.
Tolphenidone, used for its muscle-relaxing properties, often finds a spot in prescriptions for painful muscular conditions. Yet, not everyone can count on it as a safe solution. People tend to seek clarity on who shouldn’t take tolphenidone. I once saw an older neighbor take muscle relaxants after a mild fall; her doctor stopped the medicine after blood tests flagged trouble. Her case sticks with me when I think about how a straightforward drug can spell problems for some folks.
Liver disease stands out as a hard stop for tolphenidone. The medicine breaks down in the liver. If someone’s liver works poorly, the drug can build up and trigger more damage. A friend with hepatitis tried to ask about muscle relaxants and learned the hard way to check every medicine for risk. Hepatotoxicity (liver toxicity) isn’t just something you read about in journals—stories like hers show the need for awareness. Studies show that medications cleared by the liver often have strict warnings. Liver enzymes can spike, even in people with mild, silent liver disease.
There’s also a red flag for folks with a history of allergies or hypersensitivity to drugs with a similar profile. Swelling, rash, or even serious allergic reactions sometimes follow medications in this category. You never quite forget the image of someone with a swollen face in the waiting room. While rare, fast action on allergic responses saves lives. Pharmacies and clinics take detailed records for good reason. An open conversation about past reactions stops most issues before they start.
Pregnancy asks for another set of precautions. Animal studies give clues, but human data remains limited. Doctors will usually weigh risks against benefits, especially when milder options exist or pain can be managed other ways. Breastfeeding presents its own questions, since medication can pass from mom to child. Relying on real data, not hearsay, keeps both moms and babies safe. Reading the fine print on the medication insert—something doctors do all the time—makes a difference.
Risk for children and those under 18 also comes into play. Their metabolism churns at a different rate, and unpredictable reactions happen more often. Most guidelines recommend avoiding tolphenidone in younger patients, sticking with better-understood medications instead.
Beyond the specific red flags, people already on lots of medication face a tangled web of interactions. Polypharmacy isn’t rare; I’ve watched relatives try to keep track of a half-dozen pills at once. Muscle relaxants, including tolphenidone, can cause sleepiness, confusion, or falls—especially in older adults or people using sedatives, antidepressants, or alcohol. The risk isn’t small. According to studies in geriatric medicine, falls and hospital visits often skyrocket when sedative medicines mix.
Tackling these problems takes more than just reading the label. Good doctors check medical history, ask about every pill and supplement, and avoid risky drugs in frailer or older patients. Pharmacists play backstop, double-checking for dangerous combinations. As someone who’s seen a pillbox spill in a purse and turn into confusion, I know simple mistakes cause real harm.
Going forward, the best fix isn’t to just avoid tolphenidone, but to look for alternatives that fit each life story. Physical therapy, gentle movement, heat packs, or non-drug solutions serve some people better—especially for mild muscle pain. At the end of the day, it’s shared decision-making that helps people stay safe and comfortable.
Balancing medications can turn into a tricky puzzle. Tolphenidone, known for its muscle relaxant qualities, joins the ranks of drugs where interaction stories come up. Grappling with muscle pain gets tough for a lot of people, especially those already juggling other prescriptions for heart, mental health, or chronic pain conditions. I’ve seen friends and family deal with this pile-up, and questions always come up about what mixes safe and what sets up more problems.
Trust builds between patients and their doctors, but even with full faith, the risk of missed drug interactions hangs around. Many times, prescriptions get filled at different clinics or pharmacies, especially for people moving between doctors. Tolphenidone may fly under the radar during rushed check-ups, especially since it isn’t as talked-about as other muscle medications like baclofen or tizanidine.
Mixing medicines can lead to drowsiness, low blood pressure, or more serious effects. If a patient takes another drug that slows down the central nervous system—such as benzodiazepines, opioids, or sleep aids—adding Tolphenidone can leave someone groggy, confused, or even at risk for fainting. The risk jumps in older adults. In a study on medication-related falls in people over 65, drug combinations played a huge role in hospital visits.
Tolphenidone passes through the liver, just like many painkillers and antidepressants. Certain liver enzymes—namely CYP450—handle the breakdown of these chemicals. If another medication slows these enzymes, Tolphenidone's levels shoot up, which leads to stronger side effects. On the flip side, drugs that speed up these enzymes push Tolphenidone out faster, which may blunt its impact. Common meds like some anti-seizure pills, antibiotics, or antifungal drugs throw off this balance.
Pharmacovigilance databases list cases where patients taking Tolphenidone showed unexpected sleepiness, blood pressure drops, or slow breathing after adding something new into their daily mix. While not as widely prescribed as muscle relaxants used in the US, pharmacists in Europe report extra caution if Tolphenidone lands in a cart with antidepressants or antihistamines.
This risk isn’t all theory. One memorable incident: a close family member, struggling with muscle pain after a car accident, was prescribed Tolphenidone along with a low-dose antidepressant. Three days later, she complained of dizziness so severe she nearly fell stepping off her porch. After her doctor reviewed her meds, the Tolphenidone was swapped for another option, and things calmed down. These stories push home the lesson: medication history isn’t just another paper in a thick file.
Most folks don’t memorize everything about their medications. That’s why pharmacists matter—they often catch problems before they hurt someone. I always tell friends: bring a full medication list, including herbal stuff, vitamins, and over-the-counter solutions. Some clinics offer digital tools that flag risky combinations before the prescription hits the pharmacy.
Keeping up on new data helps, too. Medical journals keep reporting subtle shifts in drug risk profiles as more people hit middle age and as polypharmacy rates climb. As a patient, asking about interactions at every medication change might feel awkward, but no one protects our health better than we do when it comes to these details. A simple question—“Does this mix well with my other medications?”—has real power.
| Names | |
| Preferred IUPAC name | 3,3-diphenyl-1-(p-tolyl)propan-1-one |
| Other names |
Tolnate Tolfenidone |
| Pronunciation | /tɒlˈfɛnɪˌdoʊn/ |
| Identifiers | |
| CAS Number | 27581-02-8 |
| Beilstein Reference | 3568127 |
| ChEBI | CHEBI:9635 |
| ChEMBL | CHEMBL2110891 |
| ChemSpider | 4902 |
| DrugBank | DB08939 |
| ECHA InfoCard | 153637 |
| EC Number | EC 241-285-0 |
| Gmelin Reference | 107926 |
| KEGG | C14175 |
| MeSH | D017363 |
| PubChem CID | 5247 |
| RTECS number | XP9270000 |
| UNII | 6B9YKM8988 |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C16H15NO2 |
| Molar mass | 267.340 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.2 g/cm3 |
| Solubility in water | Slightly soluble in water |
| log P | 2.6 |
| Vapor pressure | 2.7E-8 mmHg |
| Acidity (pKa) | 4.68 |
| Basicity (pKb) | 7.42 |
| Magnetic susceptibility (χ) | -79.0e-6 cm³/mol |
| Refractive index (nD) | 1.635 |
| Viscosity | Viscous liquid |
| Dipole moment | 3.95 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 377.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -23.7 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3527 kJ/mol |
| Pharmacology | |
| ATC code | M03BC03 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. May cause respiratory irritation. |
| GHS labelling | GHS labelling: "Warning; H315, H319, H335 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | P261, P264, P270, P271, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 1-2-0-健康注意 |
| Flash point | 103.3°C |
| Autoignition temperature | 400°C |
| Explosive limits | Explosive limits: 1.2–7.0% |
| Lethal dose or concentration | LD50 (oral, rat): 820 mg/kg |
| LD50 (median dose) | LD50: 400 mg/kg (oral, mouse) |
| PEL (Permissible) | Not established |
| REL (Recommended) | 500 mg daily |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Benzydamine Fentiazac Niflumic acid |
